Kansas Administrative Regulations › Agency 28 - DEPARTMENT OF HEALTH AND ENVIRONMENT › Article 35 - RADIATION › Section 28-35-135g - Definitions

Current through Register Vol. 43, No. 28, July 11,
			 2024
As used in these regulations, each of the following terms shall
				have the meaning assigned in this regulation:
(a) "Gantry" means that part of the system
			 supporting and allowing possible movements of the radiation head.
(b) "General emergency" means that an
			 accident has occurred or is in progress, involving actual or imminent
			 catastrophic reduction of facility safety systems with the potential for loss
			 of containment or confinement integrity or release of radioactive material that
			 can be reasonably expected to exceed off-site protective action guides.
(c) "Generally applicable
			 environmental radiation standards" means standards issued by the U.S.
			 environmental protection agency (EPA) under the authority of the atomic energy
			 act of 1954, as amended, that impose limits on radiation exposures or levels,
			 or concentrations or quantities of radioactive material, in the general
			 environment outside the boundaries of locations under the control of persons
			 possessing or using radioactive material.
(d) "General purpose radiographic X-ray
			 system" means any radiographic X-ray system that, by design, is not limited to
			 the radiographic examination of specific anatomical regions.
(e) "Gonadal shield" means a protective
			 barrier for the testes or ovaries.
(f) "Gray (Gy)" means the SI unit of absorbed
			 dose. One gray is equal to an absorbed dose of one joule per kilogram. One gray
			 is also equal to 100 rads.
(g)
			 "Group I" means prepared radiopharmaceuticals that are used for diagnostic
			 studies involving measurements of uptake, dilution, and excretion, as specified
			 in 10 CFR
			 35.100, which is adopted by reference in
			 KA.R. 28-35-264.
(h) "Group II"
			 means prepared radiopharmaceuticals that are used for diagnostic studies
			 involving imaging and tumor localizations and any radioactive material in a
			 radiopharmaeutical prepared from a group II kit or providing a single dose.
			 With respect to radiopharmaceuticals prepared from group II kits or as single
			 doses, group II shall refer to the unsealed byproduct material specified in
			 10 CFR
			 35.200, which is adopted by reference in
			 K.A.R. 28-35-264.
(i) "Group III"
			 means generators and reagent kits that are used following the manufacturer's
			 instructions for the preparation of diagnostic radiopharmaceuticals. With
			 respect to generators and reagent kits, group III shall refer to the unsealed
			 byproduct material specified in
			 10 CFR
			 35.200, which is adopted by reference in
			 K.A.R. 28-35-264.
(j) "Group IV"
			 means prepared radiopharmaceuticals that are used for certain therapeutic uses
			 that do not normally require hospitalization for purposes of radiation safety.
			 With respect to uses that do not normally require hospitalization, group IV
			 shall refer to the unsealed byproduct material specified in
			 10 CFR
			 35.300, which is adopted by reference in
			 K.A.R. 28-35-264.
(k) "Group V"
			 means prepared radiopharmaceuticals for certain therapeutic uses that normally
			 require hospitalization for purposes of radiation safety. With respect to uses
			 that normally require hospitalization, group V shall refer to unsealed
			 byproduct material specified in
			 10 CFR
			 35.300, which is adopted by reference in
			 K.A.R. 28-35-264.
(l) "Group VI"
			 means sources and devices containing radioactive material used for medical
			 diagnosis and therapy, as specified in
			 10 CFR
			 35.400, which is adopted by reference in
			 K.A.R. 28-35-264.
(m) "Guide tube"
			 means a flexible or rigid tube for guiding the source assembly and the attached
			 control cable from the exposure device to the exposure head. This term may
			 include the connections necessary for attachment to the exposure device and to
			 the exposure head.